Workflow
Electro - optical Technologies
icon
Search documents
Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 2025
Globenewswire· 2025-04-30 16:00
Company Overview - Exosens is a high-tech company with over 85 years of experience in innovation, development, manufacturing, and sale of high-end electro-optical technologies [6] - The company specializes in detection components and solutions, including travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors, and light intensifier tubes [6] - Exosens is recognized as a major innovator in optoelectronics, with production and R&D conducted at 11 sites across Europe and North America, employing over 1,800 staff [6] - The company is listed on compartment A of the regulated market of Euronext Paris under the ticker EXENS and is part of the Euronext Tech Leaders segment and several indices, including SBF 120 and CAC Mid 60 [6] General Meeting Information - A Combined General Meeting for shareholders is scheduled for 23 May 2025 at 10 a.m. in Paris, France [1] - The meeting notice, including the agenda and proposed resolutions, was published in the Bulletin des Annonces Légales Obligatoires (BALO) No. 47 on 18 April 2025, with a subsequent notice to be published in BALO No. 54 on 5 May 2025 [2] - Shareholders can access and download relevant documents related to the meeting on the Exosens website [3] - Documents for the General Meeting will also be available at Exosens' registered office in Mérignac, France, in compliance with legal provisions [4] - Shareholders may inspect these documents at the registered office or request them via email during the 15 days preceding the General Meeting [5]
Exosens: Availability of 2024 Universal Registration Document
Globenewswire· 2025-04-30 15:45
Group 1 - Exosens has filed its 2024 Universal Registration Document with the French Financial Markets Authority (AMF) on April 29, 2025, under number R.25-001 [1] - The 2024 Universal Registration Document includes the Group's annual financial report, management report, Board of Directors' report on corporate governance, and sustainability report [1] - The document is available for viewing on Exosens' website and the AMF website, with printed versions obtainable upon request from the company's registered office in Mérignac, France [2] Group 2 - Exosens is a high-tech company with over 85 years of experience in the innovation, development, manufacturing, and sale of high-end electro-optical technologies [3] - The company offers detection components and solutions, including travelling wave tubes, advanced cameras, neutron and gamma detectors, instrument detectors, and light intensifier tubes [3] - Exosens is recognized as a major innovator in optoelectronics, with production and R&D across 11 sites in Europe and North America, employing over 1,800 staff [3] - The company is listed on compartment A of the regulated market of Euronext Paris and is a member of the Euronext Tech Leaders segment, included in several indices such as SBF 120 and MSCI France Small Cap [3]
Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance
Globenewswire· 2025-04-28 05:30
Core Insights - Exosens reported strong revenue growth in Q1 2025, achieving €104.9 million, a 21.1% increase compared to Q1 2024, driven by robust demand in Defense markets [7][8][10] - The company is on track to meet its 2025 guidance, expecting high-teens revenue growth and low twenties adjusted EBITDA growth [3][23] Financial Performance - Total revenue for Q1 2025 was €104.9 million, up €18.3 million from Q1 2024, with a like-for-like growth of 18.0% [6][7] - Amplification revenue reached €81.7 million, reflecting a significant growth of 29.1% year-over-year, primarily due to increased demand for night vision applications [9][10] - Detection & Imaging revenue slightly declined to €24.0 million, down 1.0% compared to Q1 2024, impacted by temporary challenges in the Telops segment [11][12] Margin Analysis - Adjusted gross margin increased by 28.1% to €52.6 million in Q1 2025, with a margin rate of 50.1%, up 270 basis points from the previous year [8][17] - The Amplification segment's adjusted gross margin grew by 39.5% to €40.8 million, with a margin rate of 49.9% [18] - Detection & Imaging segment's adjusted gross margin remained stable at €11.8 million, with a margin rate improvement to 49.3% [19] Market Dynamics - The demand for Exosens' products is bolstered by increasing geopolitical tensions and sustained investments from NATO and Tier-1 allies [4][10] - The company anticipates continued growth in its Defense-related activities, with expectations for the Detection & Imaging segment to recover and accelerate throughout 2025 [12][23] Strategic Developments - Exosens completed the acquisition of Noxant, enhancing its capabilities in high-performance cooled infrared imaging, particularly for Defense and Surveillance applications [13][14] - The integration of Noxant is underway, expected to be finalized by the end of June 2025 [14] Governance and Shareholder Updates - Bpifrance Investissement is proposed for appointment to the Board of Directors, following an increase in its stake to 7.2% of Exosens' share capital [20][21] - The company maintains a leverage ratio target of around 2x while pursuing its growth strategy [24]